- АФР
- Члены АФР
- Ширинбек Олими
| Город: | Москва |
|---|---|
| Страна: | Россия |
| Дата рождения: | 01.07.1977 |
| Место работы: | Многопрофильный медицинский холдинг "СМ-Клиника", Центр флебологии |
| Должность: | заместитель главного врача по хирургии, руководитель |
| Рабочий адрес: | Москва, Старопетровский проезд д 7а стр 22 |
| Сайт организации: | www.smclinic.ru |
| Мобильный телефон: | +7 (926) 430-73-82 |
| Ссылка на резюме: | www.smclinic.ru/rezume/olimi-shirinbek/ |
| ORCID: | https://orcid.org/0000-0003-2116-2247 |
| Сертификат: |  |
Успешная клеевая облитерация аневризмы культи большой подкожной вены при рецидиве варикозной болезни
2023
1. Lurie F., Creton D., Eklof B. Prospective randomised study of Endovenous Radiofrequency Obliteration (Closure) Versus Ligation and Vein Stripping (EVOLVeS): 2-year follow-up // J. Vasc. Surg. 2005. Vol. 42, N 1. P. 67-73. DOI: https://doi.org/10.1016/j.jvs.2005.0 4.007 2. Rasmussen L., Lawaetz M., Bjoern L., Vennits B., Blemings A., Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins // Br. J. Surg. 2011. Vol. 98, N 8. P. 1079-1087. DOI: https://doi.org/10.1002/bjs.7555 3. Hartmann K. Endovenöse (minimalinvasive) Verfahren zur Therapie der Varikose: Schonende und effektive Alternative zur Stripping-Operation [Endovenous (minimally invasive) procedures for treatment of varicose veins: The gentle and effective alternative to high ligation and stripping operations] // Hautarzt. 2020. Vol. 71, N 1. P. 12-19. (in German). DOI: https://doi.org/10.1007/s00105-019-0-4520-2 4. Morrison N., Gibson K., Vasquez M., Weiss R., Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins // J. Vasc. Surg. Venous Lymphat. Disord. 2020. Vol. 8, N 6. P. 978-989. DOI: https://doi.org/10.1016/j.jvsv.2019.12.080 5. Almeida J., Javier J., Mackay E., Bautista C., Cher D., Proebstle T. Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence // Phlebology. 2014. Vol. 30, N 6. P. 397-404. DOI: https://doi.org/10.1177/0268355514532455 6. Gibson K., Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a postmarket evaluation of the VenaSeal System (the WAVES Study) // Vascular. 2016. Vol. 25, N 2. P. 149-156. DOI: https://doi.org/10.1177/1708538116651014 7. Proebstle T., Alm J., Dimitri S., Rasmussen L., Whiteley M., Lawson J. et al. Three-year follow-up results of the prospective European Multi-center Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins // J. Vasc. Surg. Venous Lymphat. Disord. 2021. Vol. 9, N 2. P. 329-334. DOI: https://doi.org/10.1016/j.jvsv.2020.05.019 8. Teng M., Chen C., Lirng J., Chen S., Lee L., Chang T. N-butyl-2-cyanoacrylate for embolisation of carotid aneurysm // Neuroradiology. 1994. Vol. 36, N 2. P. 144-147. DOI: https://doi.org/10.1007/bf00588084 9. Min R., Almeida J., Mclean D., Madsen M., Raabe R. Novel vein closure procedure using a proprietary cyanoacrylate adhesive: 30-day swine model results // Phlebology. 2012. Vol. 27, N 8. P. 398-403. DOI: https://doi.org/10.1258/phleb.2011.011084 10. Vos C., Ünlü Ç., Bosma J., van Vlijmen C., de Nie A., Schreve M. A systematic review and metaanalysis of two novel techniques of nonthermal endovenous ablation of the great saphenous vein // J. Vasc. Surg. Venous Lymphat. Disord. 2017. Vol. 5, N 6. P. 880-896. DOI: https://doi.org/10.1016/j.jvsv.2017.05.022 11. Bozkurt A., Yılmaz M. A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency // Phlebology. 2016. Vol. 31, N 1. Suppl. P. 106-113. DOI: https://doi.org/10.1177/0268355516632652 12. Proebstle T., Alm J., Dimitri S., Rasmussen L., Whiteley M., Lawson J. et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins // J. Vasc. Surg. Venous Lymphat. Disord. 2015. Vol. 3, N 1. P. 2-7. DOI: https://doi.org/10.1016/j.jvsv.2014.09.001 13. Park I. Successful use of VenaSeal system for the treatment of large great saphenous vein of 2.84-cm diameter // Ann. Surg. Treat. Res. 2018. Vol. 94, N 4. P. 219-221. DOI: https://doi.org/10.4174/astr.2018.94.4.219 14. Ширинбек О., Мнацаканян Г.В., Одинокова С.Н. Цианоакрилатная клеевая облитерация варикозных вен в реальной клинической практике: двухлетние результаты лечения // Амбулаторная хирургия. 2022. Т. 19, № 1. С. 132-139. DOI: https://doi.org/10.21518/1995-1477-2022-19-1-132-139 15. Ширинбек О. Клеевая облитерация магистральных подкожных вен : руководство для врачей. Москва : ГЭОТАР-Медиа, 2022. 16. Morrison N., Gibson K., Vasquez M., Weiss R., Cher D., Madsen M. et al. VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins // J. Vasc. Surg. Venous Lymphat. Disord. 2017. Vol. 5, N 3. P. 321-330. DOI: https://doi.org/10.1016/j.jvsv.2016.12.005 17. Chan Y.C., Law Y., Cheung G.C., Cheng S.W. Predictors of recanalization for incompetent great saphenous veins treated with cyanoacrylate glue // J. Vasc. Interv. Radiol. 2017. Vol. 28, N 5. P. 665-671. DOI: https://doi.org/10.1016/j.jvir.2017.01.011 18. Мурзина Е.Л., Лобастов К.В., Барганджия А.Б., Лаберко Л.А., Попов И.Б. Среднесрочные результаты цианоакрилатной эмболизации магистральных подкожных вен // Флебология. 2020. Т. 14, № 4. С. 311-321. DOI: https://doi.org/10.17116/flebo2020140 41311 19. Беленцов С М. Клеевая технология устранения патологического вено-венозного рефлюкса при хронических заболеваниях вен нижних конечностей: ближайшие и отдаленные результаты // Амбулаторная хирургия. 2021, Т. 18, № 1. С. 48-54. DOI: https://doi.org/10.21518/1995-1477-2021-18-1-48-54
Цианоакрилатная клеевая облитерация в европейских и американских клинических рекомендациях 2022 года
2023
1. Bootun R, Lane TR, Davies AH. The advent of non-thermal, non-tumescent techniques for treatment of varicose veins. Phlebology. 2016 Feb;31(1):5-14. doi: 10.1177/0268355515593186. Epub 2015 Jun 30. PMID: 26130051. 2. Whiteley MS. Glue, steam and Clarivein--Best practice techniques and evidence. Phlebology. 2015 Nov;30(2 Suppl):24-8. doi: 10.1177/0268355515591447. PMID: 26556699. 3. Whiteley MS. Current Best Practice in the Management of Varicose Veins. Clin Cosmet Investig Dermatol. 2022 Apr 6;15:567-583. doi: 10.2147/CCID.S294990. PMID: 35418769; PMCID: PMC8995160. 4. van Eekeren RR, Boersma D, Elias S, Holewijn S, Werson DA, de Vries JP, Reijnen MM. Endovenous mechanochemical ablation of great saphenous vein incompetence using the ClariVein device: a safety study. J Endovasc Ther. 2011 Jun;18(3):328-34. doi: 10.1583/11-3394.1. PMID: 21679070. 5. Witte ME, Reijnen MM, de Vries JP, Zeebregts CJ. Mechanochemical Endovenous Occlusion of Varicose Veins Using the ClariVein® Device. Surg Technol Int. 2015 May; 26:219-25. PMID: 26055013. 6. Almeida JI, Javier JJ, Mackay E, Bautista C, Proebstle TM. First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2013 Apr;1(2):174-80. doi: 10.1016/j.jvsv.2012.09.010. Epub 2012 Dec 22. PMID: 26992340. 7. Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):658-666. doi: 10.1016/j.jvsv.2017.03.016. Epub 2017 Jun 2. PMID: 28818217. 8. De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfé N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Björck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022 Feb;63(2):184-267. doi: 10.1016/j.ejvs.2021.12.024. Epub 2022 Jan 11. Erratum in: Eur J Vasc Endovasc Surg. 2022 Aug-Sep;64(2-3):284-285. PMID: 35027279. 9. Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S, de Wolf M, Eggen C, Giannoukas A, Gohel M, Kakkos S, Lawson J, Noppeney T, Onida S, Pittaluga P, Thomis S, Toonder I, Vuylsteke M, Esvs Guidelines Committee, Kolh P, de Borst GJ, Chakfé N, Debus S, Hinchliffe R, Koncar I, Lindholt J, de Ceniga MV, Vermassen F, Verzini F, Document Reviewers, De Maeseneer MG, Blomgren L, Hartung O, Kalodiki E, Korten E, Lugli M, Naylor R, Nicolini P, Rosales A. Editor's Choice - Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2015 Jun;49(6):678-737. doi: 10.1016/j.ejvs.2015.02.007. Epub 2015 Apr 25. Erratum in: Eur J Vasc Endovasc Surg. 2020 Mar;59(3):495. PMID: 25920631. 10. Gloviczki P, Lawrence PF, Wasan SM, Meissner MH, Almeida J, Brown KR, Bush RL, Di Iorio M, Fish J, Fukaya E, Gloviczki ML, Hingorani A, Jayaraj A, Kolluri R, Murad MH, Obi AT, Ozsvath KJ, Singh MJ, Vayuvegula S, Welch HJ. The 2022 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part I. Duplex Scanning and Treatment of Superficial Truncal Reflux: Endorsed by the Society for Vascular Medicine and the International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2022 Oct 12:S2213-333X(22)00417-6. doi: 10.1016/j.jvsv.2022.09.004. Epub ahead of print. PMID: 36326210. 11. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, Lohr JM, McLafferty RB, Meissner MH, Murad MH, Padberg FT, Pappas PJ, Passman MA, Raffetto JD, Vasquez MA, Wakefield TW; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011 May;53(5 Suppl):2S-48S. doi: 10.1016/j.jvs.2011.01.079. PMID: 21536172. 12. Parsi K, Roberts S, Kang M, Benson S, Baker L, Berman I, Bester LJ, Connor DE, Dinnen P, Grace J, Stirling A, Ibrahim N, Lekich C, Lim A, Matar L, Nadkarni S, Paraskevas P, Rogan C, Thibault PK, Thibault S, van Rij A, Yang A. Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology. Phlebology. 2020 Apr;35(3):153-175. doi: 10.1177/0268355519864755. Epub 2019 Aug 1. PMID: 31368408. 13. Almeida JI, Murray SP, Romero ME. Saphenous vein histopathology 5.5 years after cyanoacrylate closure. J Vasc Surg Venous Lymphat Disord. 2020 Mar;8(2):280-284. doi: 10.1016/j.jvsv.2019.04.014. Epub 2019 Jul 4. PMID: 31281102. 14. Park I. Human Saphenous Vein Histopathology 2 Years After Cyanoacrylate Closure Using the VenaSeal™ System. Ann Vasc Surg. 2021 Feb;71:534.e17-534.e21. doi: 10.1016/j.avsg.2020.09.017. Epub 2020 Sep 16. PMID: 32949737. 15. Ontario Health (Quality). Nonthermal Endovenous Procedures for Varicose Veins: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021 Jun 4;21(8):1-188. PMID: 34211617; PMCID: PMC8208443. 16. Morrison N, Gibson K, McEnroe S, Goldman M, King T, Weiss R, Cher D, Jones A. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015 Apr;61(4):985-94. doi: 10.1016/j.jvs.2014.11.071. Epub 2015 Jan 31. PMID: 25650040. 17. Morrison N, Kolluri R, Vasquez M, Madsen M, Jones A, Gibson K. Comparison of cyanoacrylate closure and radiofrequency ablation for the treatment of incompetent great saphenous veins: 36-Month outcomes of the VeClose randomized controlled trial. Phlebology. 2019 Jul;34(6):380-390. doi: 10.1177/0268355518810259. Epub 2018 Nov 7. PMID: 30403154; PMCID: PMC6587361. 18. Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):978-989. doi: 10.1016/j.jvsv.2019.12.080. Epub 2020 Mar 20. PMID: 32205125. 19. Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. 2017 Apr;25(2):149-156. doi: 10.1177/1708538116651014. Epub 2016 Jul 9. PMID: 27206470. 20. Gibson K, Minjarez R, Gunderson K, Ferris B. Need for adjunctive procedures following cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of postprocedure compression: Three-month data from a postmarket evaluation of the VenaSeal System (the WAVES Study). Phlebology. 2019 May;34(4):231-237. doi: 10.1177/0268355518801641. Epub 2018 Sep 18. PMID: 30227791. 21. Bahi M, Guazzo L, Taumoepeau L. Real-world short-term VenaSeal ablation outcomes for symptomatic saphenous incompetence. Vascular. 2022 Feb 25:17085381221077511. doi: 10.1177/17085381221077511. Epub ahead of print. PMID: 35209758. 22. Kolluri R, Chung J, Kim S, Nath N, Bhalla BB, Jain T, Zygmunt J, Davies A. Network meta-analysis to compare VenaSeal with other superficial venous therapies for chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2020 May;8(3):472-481.e3. doi: 10.1016/j.jvsv.2019.12.061. Epub 2020 Feb 14. PMID: 32063522. 23. El Kilic H, Bektas N, Bitargil M, Balkaya IA, Demir T, Koramaz I. Long-term outcomes of endovenous laser ablation, n-butyl cyanoacrylate, and radiofrequency ablation for treatment of chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022 Jul;10(4):865-871. doi: 10.1016/j.jvsv.2021.10.009. Epub 2021 Oct 22. PMID: 34688972. 24. Kubat E, Ünal CS, Geldi O, Çetin E, Keskin A, Karapınar K. Comparison of different approaches to small saphenous vein reflux treatment: a retrospective study in two centers. Sao Paulo Med J. 2020 Mar;138(2):98-105. doi: 10.1590/1516-3180.2019.0230.r1.06112019. Epub 2020 Jun 1. PMID: 32491084; PMCID: PMC9662839. 25. Park I, Jeong MH, Park CJ, Park WI, Park DW, Joh JH. Clinical Features and Management of "Phlebitis-like Abnormal Reaction" After Cyanoacrylate Closure for the Treatment of Incompetent Saphenous Veins. Ann Vasc Surg. 2019 Feb;55:239-245. doi: 10.1016/j.avsg.2018.07.040. Epub 2018 Sep 11. PMID: 30217712 26. Gibson K, Minjarez R, Rinehardt E, Ferris B. Frequency and severity of hypersensitivity reactions in patients after VenaSeal™ cyanoacrylate treatment of superficial venous insufficiency. Phlebology. 2020 Jun;35(5):337-344. doi: 10.1177/0268355519878618. Epub 2019 Sep 25. PMID: 31554473. 27. Toonder IM, Lam YL, Lawson J, Wittens CH. Cyanoacrylate adhesive perforator embolization (CAPE) of incompetent perforating veins of the leg, a feasibility study. Phlebology. 2014 May;29(1 suppl):49-54. doi: 10.1177/0268355514529696. Epub 2014 May 19. PMID: 24843086. 28. Joh JH, Lee T, Byun SJ, Cho S, Park HS, Yun WS, Yang SS, Kim H, Kim WS, Jung IM. A multicenter randomized controlled trial of cyanoacrylate closure and surgical stripping for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2022 Mar;10(2):353-359. doi: 10.1016/j.jvsv.2021.08.012. Epub 2021 Aug 23. PMID: 34438091. 29. Cho S, Joh JH. Cyanoacrylate Closure of Small Saphenous Vein Insufficiency. Dermatol Surg. 2021 Mar 1;47(3):381-384. doi: 10.1097/DSS.0000000000002748. PMID: 33625155.
Нежелательные явления и осложнения после цианоакрилатной клеевой облитерации варикозных вен
2023
1. Parsi K, Roberts S, Kang M et al. Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology. Phlebology: The Journal of Venous Disease. 2019;35(3):153-175. doi:10.1177/0268355519864755 2. Edwards H, Day J. Fourier transform Raman spectroscopic studies of the curing of cyanoacrylate glue. Journal of Raman Spectroscopy. 2004;35(7):555-560. doi:10.1002/jrs.1184 3. Беленцов С.М. Клеевая технология устранения патологического вено-венозного рефлюкса при хронических заболеваниях вен нижних конечностей: ближайшие и отдаленные результаты. Амбулаторная хирургия. 2021;18(1):48–54. https://doi.org/10.21518/1995-1477-2021-18-1-48-54. 4. Мурзина Е.Л., Лобастов К.В., Барганджия А.Б., Лаберко Л.А., Попов И.Б. Среднесрочные результаты цианоакрилатной эмболизации магистральных подкожных вен. Флебология. 2020;14(4):311 321. https://doi.org/10.17116/flebo202014041311 5. Ширинбек О., Одинокова С.Н. Цианоакрилатная клеевая облитерация подкожных вен. Флебология. 2021;15(4):297 303.https://doi.org/10.17116/flebo202115041297 6. Ширинбек О. Клеевая облитерация магистральных подкожных вен: руководство для врачей. Москва: ГЭОТАР-Медиа; 2022:48. doi: 10.33029/9704-7103-6-KOV-2022-1-48. 7. Ширинбек О., Мнацаканян Г.В., Одинокова С.Н. Цианоакрилатная клеевая облитерация варикозных вен в реальной клинической практике: двухлетние результаты лечения. Амбулаторная хирургия. 2022;19(1):132-139. https://doi.org/10.21518/1995-1477-2022-19-1-132-139 8. Kumar V, Abbas A, Aster J, Perkins J. Robbins Basic Pathology. Philadelphia: Elsevier; 2018. 9. Gibson K, Ferris B. Cyanoacrylate closure of incompetent great, small and accessory saphenous veins without the use of post-procedure compression: Initial outcomes of a post-market evaluation of the VenaSeal System (the WAVES Study). Vascular. 2016;25(2):149-156. doi:10.1177/1708538116651014 10. Park I, Jeong M, Park C, Park W, Park D, Joh J. Clinical Features and Management of “Phlebitis-like Abnormal Reaction” After Cyanoacrylate Closure for the Treatment of Incompetent Saphenous Veins. Ann Vasc Surg. 2019;55:239-245. doi:10.1016/j.avsg.2018.07.040 11. Yacoub M, Lemière C, Malo J. Asthma caused by cyanoacrylate used in a leisure activity. Journal of Allergy and Clinical Immunology. 2005;116(2):462-462. doi:10.1016/j.jaci.2005.04.015 12. Watts T, Thursfield D, Haque R. Allergic contact dermatitis caused by VenaSeal tissue adhesive. Contact Dermatitis. 2019;80(6):393-395. doi:10.1111/cod.13206 13. Montgomery R, Stocks S, Wilkinson S. Contact allergy resulting from the use of acrylate nails is increasing in both users and those who are occupationally exposed. Contact Dermatitis. 2016;74(2):120-122. doi:10.1111/cod.12497 14. Andujar R, Cruz M, Villar A, Morell F, Muñoz X. High eosinophil levels and poor evolution in occupational asthma due to cyanoacrylate exposure. Am J Ind Med. 2011;54(9):714-718. doi:10.1002/ajim.20953 15. Almeida J, Javier J, Mackay E, Bautista C, Cher D, Proebstle T. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2017;5(5):658-666. doi:10.1016/j.jvsv.2017.03.016 16. Proebstle T, Alm J, Dimitri S et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2015;3(1):2-7. doi:10.1016/j.jvsv.2014.09.001 17. Morrison N, Gibson K, McEnroe S et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985-994. doi:10.1016/j.jvs.2014.11.071 18. Bozkurt A, Yılmaz M. A prospective comparison of a new cyanoacrylate glue and laser ablation for the treatment of venous insufficiency. Phlebology: The Journal of Venous Disease. 2016;31(1_suppl):106-113. doi:10.1177/0268355516632652 19. Koramaz İ, El Kılıç H, Gökalp F et al. Ablation of the great saphenous vein with nontumescent n-butyl cyanoacrylate versus endovenous laser therapy. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2017;5(2):210-215. doi:10.1016/j.jvsv.2016.09.007 20. Yavuz T, Acar A, Aydın H, Ekingen E. A retrospective study of a new n-butyl-2-cyanoacrylate glue ablation catheter incorporated with application guiding light for the treatment of venous insufficiency: Twelve-month results. Vascular. 2018;26(5):547-555. doi:10.1177/1708538118770548 21. Tekin A, Tuncer O, Memetoğlu M et al. Nonthermal, Nontumescent Endovenous Treatment of Varicose Veins. Ann Vasc Surg. 2016; 36:231-235. doi:10.1016/j.avsg.2016.03.005 22. Chan Y, Law Y, Cheung G, Ting A, Cheng S. Cyanoacrylate glue used to treat great saphenous reflux: Measures of outcome. Phlebology: The Journal of Venous Disease. 2016;32(2):99-106. doi:10.1177/0268355516638200 23. Tseng Y, Ma L, Luo T et al. Thromboembolic Events Secondary to Endoscopic Cyanoacrylate Injection: Can We Foresee Any Red Flags? Canadian Journal of Gastroenterology and Hepatology. 2018;2018:1-10. doi:10.1155/2018/1940592 24. Lam Y, De Maeseneer M, Lawson J, De Borst G, Boersma D. Expert review on the VenaSeal® system for endovenous cyano-acrylate adhesive ablation of incompetent saphenous trunks in patients with varicose veins. Expert Rev Med Devices. 2017;14(10):755-762. doi:10.1080/17434440.2017.1378093
Цианоакрилатная клеевая облитерация варикозных вен в реальной клинической практике: двухлетние результаты лечения
2022
1. Belramman A., Bootun R., Lane T., Davies A. Endovenous Management of Varicose Veins. Angiology. 2018;70(5):388–396. https://doi.org/10.1177/0003319718780049. 2. Robertson L., Evans C., Fowkes F. Epidemiology of chronic venous disease. Phlebology: J Ven Dis. 2008;23(3):103–111. https://doi.org/10.1258/phleb.2007.007061. 3. Yang G., Parapini M., Gagnon J., Chen J. Comparison of cyanoacrylate embolization and radiofrequency ablation for the treatment of varicose veins. Phlebology: J Ven Dis. 2018;34(4): 278–283. https://doi.org/10.1177/0268355518794105. 4. Bootun R., Onida S., Lane T. Varicose veins and their management. Surgery (Oxford). 2016;34(4):165–171. https://doi.org/10.1016/j.mpsur.2016.02.002. 5. Kugler N., Brown K. An update on the currently available nonthermal ablative options in the management of superficial venous disease. J Vasc Surg Venous Lymphat Disord. 2017;5(3):422–429. https://doi.org/10.1016/j.jvsv.2017.01.014. 6. Braithwaite B., Hnatek L., Zierau U., Camci M., Akkersdijk G., Nio D. Radiofrequency-induced thermal therapy: results of a European multicentre study of resistive ablation of incompetent truncal varicose veins. Phlebology: J Ven Dis. 2012;28(1):38–46. https://doi.org/10.1258/phleb.2012.012013. 7. Lurie F., Creton D., Eklof B. Prospective randomised study of Endovenous Radiofrequency Obliteration (Closure) Versus Ligation and Vein Stripping (EVOLVeS): 2-year follow-up. J Vasc Sur. 2005;42(1):178. https://doi.org/10.1016/j.jvs.2005.04.007. 8. Rasmussen L., Lawaetz M., Bjoern L., Vennits B., Blemings A., Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Sur. 2011;98(8):1079–1087. https://doi.org/10.1002/bjs.7555. 9. Cтойко Ю.М., Кириенко А.И., Затевахин И.И., Покровский А.В., Карпенко А.А., Золотухин И.А. и др. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология. 2018;(3):188. Режим доступа: https://phlebology-sro.ru/upload/iblock/23d/rossiyskie-klinicheskie-rekomendatsii-po-khzv-2018.pdf. Ctoiko Yu.M., Kirienko A.I., Zatevakhin I.I., Pokrovskii A.V., Karpenko A.A., Zolotukhin I.A. et al. Diagnostics and Treatment of Chronic Venous Disease: Guidelines of Russian Phlebological Association. Flebologiya. 2018;(3):188. (In Russ.) Available at: https://phlebology-sro.ru/upload/iblock/23d/rossiyskieklinicheskie-rekomendatsii-po-khzv-2018.pdf. 10. Davies A., Azzam M., Bradbury A., Brookes J., Calam J., Evans D. et al. Varicose veins: diagnosis and management. Clinical guideline [CG168]. Available at: https://www.nice.org.uk/guidance/CG168. 11. Gloviczki P., Dalsing M., Eklöf B., Lurie F., Wakefield T., Monika L., Gloviczki M. (eds.). Handbook of Venous and Lymphatic Disorders. 4th ed. NY: CRC Press; 2017. 815 p. https://doi.org/ 10.1201/9781315382449. 12. Wittens C., Davies A., Bækgaard N., Broholm R., Cavezzi A., Chastanet S. Editor’s Choice – Management of Chronic Venous Disease. Eur J Vas End Sur. 2015;49(6):678–737. https://doi.org/ 10.1016/j.ejvs.2015.02.007. 13. Nesbitt C., Bedenis R., Bhattacharya V., Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Coch Dat Syst Rev. 2014. https://doi.org/10.1002/14651858.cd005624.pub3. 14. Davies H., Popplewell M., Darvall K., Bate G., Bradbury A. A review of randomised controlled trials comparing ultrasound-guided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology: J Ven Dis. 2015;31(4):234–240. https://doi.org/ 10.1177/0268355515595194. 15. Vos C., Ünlü Ç., Bosma J., van Vlijmen C., de Nie A., Schreve M. A systematic review and meta-analysis of two novel techniques of nonthermal endovenous ablation of the great saphenous vein. J Vasc Surg Venous Lymphat Disord. 2017;5(6):880–896. https://doi.org/10.1016/j.jvsv.2017.05.022. 16. Tang T., Rathnaweera H., Kam J., Chong T., Choke E., Tan Y. Endovenous Cyanoacrylate Glue to Treat Varicose Veins and Chronic Venous Insufficiency-Experience Gained From Our First 100+ Truncal Venous Ablations in a Multi-Ethnic Asian Population Using the Medtronic VenaSeal Closure System. J Vasc Surg Venous Lymphat Disord. 2019;7(5):764. https://doi.org/10.1016/j.jvsv.2019.06.007. 17. Labenz J., Börsch G. Successful Endoscopic Hemostasis of Duodenal Variceal Bleeding with Histoacryl. Endoscopy. 1993;25(02):194–194. https://doi.org/10.1055/s-2007-1010287. 18. Teng M., Chen C., Lirng J., Chen S., Lee L., Chang T. N-butyl-2-cyanoacrylate for embolisation of carotid aneurysm. Neuroradiology. 1994;36(2):144–147. https://doi.org/10.1007/bf00588084. 19. Min R., Almeida J., Mclean D., Madsen M., Raabe R. Novel vein closure procedure using a proprietary cyanoacrylate adhesive: 30-day swine model results. Phlebology: J Ven Dis. 2012;27(8): 398–403. https://doi.org/10.1258/phleb.2011.011084. 20. Almeida J., Min R., Raabe R., McLean D., Madsen M. Cyanoacrylate Adhesive for the Closure of Truncal Veins. Vas Endovas Surg. 2011;45(7):631–635. https://doi.org/ 10.1177/1538574411413938. 21. Almeida J., Javier J., Mackay E., Bautista C., Proebstle T. Cyanoacrylate Glue Great Saphenous Vein Ablation: Preliminary 180-Day Follow-Up of a First-In-Man Feasibility Study of a No Compression-No-Local-Anesthesia Technique. J Vas Sur. 2012;55(1):297. https://doi.org/10.1016/j.jvs.2011.11.008. 22. Lam Y., De Maeseneer M., Lawson J., De Borst G., Boersma D. Expert review on the VenaSeal® system for endovenous cyano-acrylate adhesive ablation of incompetent saphenous trunks in patients with varicose veins. Exp Rev Med Dev. 2017;14(10): 755–762. https://doi.org/10.1080/17434440.2017.1378093. 23. Хартманн К. (ред.). Минимально инвазивное лечение варикозного расширения вен нижних конечностей. М.: ГЭОТАР-Медиа; 2018. 176 с. Khartman K. (ed.). Minimally Invasive Varicose Vein Treatment Moscow: GEOTAR-Media; 2018. 176 p. (In Russ.). 24. Almeida J., Javier J., Mackay E., Bautista C., Proebstle T. First human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2013;1(2):174–180. https://doi.org/10.1016/j.jvsv.2012.09.010. 25. Almeida J., Javier J., Mackay E., Bautista C., Cher D., Proebstle T. Two-year follow-up of first human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. Phlebology: J Ven Dis. 2014;30(6):397–404. https://doi. org/10.1177/0268355514532455. 26. Proebstle T., Alm J., Dimitri S., Rasmussen L., Whiteley M., Lawson J. et al. The European multicenter cohort study on cyanoacrylate embolization of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2015;3(1):2–7. https://doi. org/10.1016/j.jvsv.2014.09.001. 27. Proebstle T., Alm J., Dimitri S., Rasmussen L., Whiteley M., Lawson J. et al. Three-year follow-up results of the prospective European Multicenter Cohort Study on Cyanoacrylate Embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. https://doi.org/10.1016/j.jvsv.2020.05.019. 28. Morrison N., Gibson K., McEnroe S., Goldman M., King T., Weiss R. et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vas Sur. 2015;61(4):985–994. https://doi. org/10.1016/j.jvs.2014.11.071. 29. Morrison N., Gibson K., Vasquez M., Weiss R., Cher D., Madsen M. et al. VeClose trial 12-month outcomes of cyanoacrylate closure versus radiofrequency ablation for incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2017;5(3):321–330. https://doi.org/10.1016/j.jvsv.2016.12.005. 30. Gibson K., Morrison N., Kolluri R., Vasquez M., Weiss R., Cher D. et al. Twenty-four month results from a randomized trial of cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2018;6(5):606–613. https://doi.org/10.1016/j.jvsv.2018.04.009. 31. Morrison N., Kolluri R., Vasquez M., Madsen M., Jones A., GibsonK. Comparison of cyanoacrylate closure and radiofrequency ablation for the treatment of incompetent great saphenous veins: 36-Month outcomes of the VeClose randomized controlled trial. Phlebology: J Ven Dis. 2018;34(6):380–390. https://doi.org/ 10.1177/0268355518810259. 32. Morrison N., Gibson K., Vasquez M., Weiss R., Jones A. Fiveyear extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020;8(6):978–989. https://doi.org/10.1016/j.jvsv.2019.12.080. 33. Беленцов С.М. Клеевая технология устранения патологического вено-венозного рефлюкса при хронических заболеваниях вен нижних конечностей: ближайшие и отдаленные результаты. Амбулаторная хирургия. 2021;18(1):48–54. https://doi.org/10.21518/1995-1477-2021-18-1-48-54. Belentsov S.M. VenaSeal for vertical veno-venous reflux elimination in patients with chronic venous disease. Ambulatornaya Khirurgiya. 2021;18(1):48–54. (In Russ.) https://doi.org/ 10.21518/1995-1477-2021-18-1-48-54. 34. Мурзина Е.Л., Лобастов К.В., Барганджия А.Б., Лаберко Л.А., Попов И.Б. Среднесрочные результаты цианоакрилатной эмболизации магистральных подкожных вен. Флебология. 2020;14(4):311 321. https://doi.org/10.17116/ flebo202014041311 Murzina E.L., Lobastov K.V., Bargandzhiya A.B., Laberko L.A., Popov I.B. Mid-Term Results of Cyanoacrylate Embolization of Saphenous Veins. Flebologiya. 2020;14(4):311 321. (In Russ.) https://doi.org/10.17116/flebo202014041311
Цианоакрилатная клеевая облитерация подкожных вен
2021
См.вложение
Фармакотерапия хронических заболеваний вен: возможности cулодексида
2015
1. Коваленко В., Калитко И., Темрезов М., Чемурзиев Р., Петров А. Возможности лечения больных с атеротромботическим поражением артерий нижних конечностей. Врач, 2010, 3: 1-3. 2. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология, 2013, 2: 47. 3. Токмакова А.Ю., Анциферов М.Б., Дедов И.И. Медикаментозная терапия ишемии нижних конечностей у больных сахарным диабетом 2-го типа. Сахарный диабет, 1999, 16: 39-42. 4. Аndreozzi GM, Cordova RM, Scomparin A et al. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region. Int Angiol., 2005, 24(3): 272-7. 5. Andreozzi G.M., Palareti G. Rationale and study design of the SURVET trial (Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis).Pathophysiology of hemostasis and thrombosis. Proceedings for the 21st International Congress on Thrombosis, Milan, July 5-9, 2010; 37:9-10, p.302. 6. Andreozzi GM. Sulodexide in the treatment of chronic venous disease. Am J Cardiovasc Drugs, 2012; doi 10.2165. 7. Bergan JJ, Schmid-Schonbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med, 2006, 3; 355(5):488-98. 8. Capone-Braga M, Tellini L, Boncompagni L, et al. Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations. Clin Ter, 1987, 15; 120 (1):25-31. 9. Carpentier PH, Maricq HR, Biro C, et al. Prevalence, risk factors and clinical patterns of chronic venous disorders of lower limbs. A population-based study in France. J Vasc Surg, 2004, 40: 650-659. 10. Cirujeda LJ, Granado CP. A study on the safety, efficacy, and efficiency of sulodexide compared with acenocumarol in secondary prophylaxis in patients with deep venous thrombosis. Angiology, 2—6, 57(1): 53-64. 11. Ciszewicz M, Polubinska A, Antoniewicz AA et al. Sulodexide suppresses inflammation in human endothelial cells and prevents glucose cytotoxicity. Transl Res, 2009, 153(3): 118-23. 12. Coccheri S, Scondotto G, Agnelli G, Aloisi D et al. Randomised, double-blind, multicentre, placebo controlled study of sulodexide in the treatment of venous leg ulcers. Thromb Haemost, 2002, 87:947-52. 13. Coccheri S, Scondotto G, Agnelli G, Palazzini E et al. Sulodexide in the treatment of intermittent claudication. Results of a randomised, double-blind, multicentre, placebocontrolled study. European Heart Journal, 2002, 23:1057-1065. 14. Cosmi B, Cini M, Legnani C, et al. Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide? A natural mixture of glycosaminoglicans. Thromb Res, 2003, 15, 109 (5-6):333-9. 15. Cospite M, Ferrara F, Cospite V, Palazzini E. Sulodexide and the microcirculatory component in microphlebopathies. Current Medical Research and Opinion, 1992, 13(1): 56-60. 16. Current aspects in chronic venous disease: focus on sulodexide. International Angiology, 2014, 33(3): 209-274. 17. Errichi BM, Cesarone MR, Belcaro G, Marinucci R et al. Prevention of recurrent deep venous thrombosis with sulodexide: The SanVal Registry. Angiology, 2004, 55(3): 243-249. 18. Gaddi A, Galetti C, Illuminati B, Nascetti S. Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease. The Journal of International Medical Research, 1996, 24: 389-406. 19. Gloviczki P, Comerota AJ, Dalsing MC et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg, 2011, 53(5): 2S-48S. 20. Guidelines Italian College of Phlebology Revision 2013. International Angiology, 2013, 32, Suppl.1 to issue No 4, 140p. 21. Jawien A, Grzela T, Ochwat A. Prevalence of chronic venous insufficiency in men and women in Poland: multicenter crosssectional study in 40 095 patients. Phlebology, 2003, 18: 110-121. 22. Kearon C, Kahn SR, Agnelli G, et al. Antothrombotic therapy for venous thromboembolic disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest, 2008, 133(6): 454S-545S. 23. Kistner RL, Eklof B, Masuda EM. Diagnosis of chronic venous disease of the lower extremities: the «CEAP» classification. Mayo Clin Proc, 1996; 71: 338-345. 24. Kucharzewski M, Franek A, Koziolek H. Treatment of venous leg ulcers with sulodexide. Phlebologie, 2003, 32: 115-20. 25. Lauver DA, Booth EA, White AJ et al. Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. J Pharmacol Exp Ther, 2005, 312(2): 794-800. 26. Manello F, Raffetto JD. Matrix metalloproteinase activity and glycosaminoglycans in chronic venous disease: the linkage among cell biology, pathology and translational research. Am J Transl Res, 2011, 3(2): 149-58. 27. Mauro M, Palmieri GC, Palazzini E, et al. Pharmacodynamic effects of single and repeated doses of oral sulodexide in healthy volunteers: a placebo-controlled study with an enteric-coated formulation. Curr Med Res Opin, 1993, 13(2): 96-108. 28. Messa GL, La Placa G, Puccetti L, et al. Pharmacodynamic effects of sulodexide on profibrinolytic and haemorrheological patterns. Clin Drug Investig, 1995, 10(3): 165-71. 29. Nelson EA, Cullum N, Jones J. Venous leg ulcers. Clin Evid, 2006, 15: 2607-26. 30. Nelson EA, Jones J. Venous leg ulcers. Clin Evid (online), 2008. 31. Nicolaides AN. Chronic venous disease and the leukocyteendothelium interaction: from symptoms to ulceration. Angiology, 2005 Sep-Oct; 56 Suppl.1 S11-9. 32. Ofosu FA. Pharmacological actions of sulodexide. Seminars on thrombosis and hemostasis. 1998, 24(2): 127-138 33. Pannier F, Rabe E. Progression of Chronic Venous Disorders: Results from the Bonn Vein Study. Journal of Vasc Surg, 2001, 53(1): 254-255. 34. Pinto A, Corrao S, Galati D, Arnone S et al. Sulodexide versus calcium heparin in the medium-term treatment of deep vein thrombosis of the lower limbs. Angiology. The Journal of Vascular Diseases, 1997, 48(9): 805-811. 35. Rabe E, Pannier F. What have we learned from the Bonn study. Phlebolymphology, 2006, 13(4): 188-193. 36. Saviano M, Maleti O, Liguori L. Double-blind,double-dummy, randomized,multicentre clinical assessment of the efficacy, tolerability, and dose-effect relationship of sulodexide in chronic venous insufficiency. Сurr Med Res Opin, 1993, 13(2): 96-108. 37. Scondotto G, Aloisi D, Ferrari P, et al. Treatment of venous leg ulcers with sulodexide. Angiology, 1999, 50(11): 883-9. 38. Takase S, Bergan JJ, Schmid-Schonbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg, 2000, 14(5): 427-35